KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Revenue (2016 - 2025)

Idexx Laboratories has reported Current Deferred Revenue over the past 17 years, most recently at $35.3 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $35.3 million for Q4 2025, up 4.33% from a year ago — trailing twelve months through Dec 2025 was $35.3 million (up 4.33% YoY), and the annual figure for FY2025 was $35.3 million, up 4.33%.
  • Current Deferred Revenue for Q4 2025 was $35.3 million at Idexx Laboratories, down from $35.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for IDXX hit a ceiling of $41.6 million in Q1 2021 and a floor of $33.8 million in Q4 2024.
  • Median Current Deferred Revenue over the past 5 years was $38.0 million (2022), compared with a mean of $38.3 million.
  • Biggest five-year swings in Current Deferred Revenue: grew 13.25% in 2021 and later dropped 9.13% in 2024.
  • Idexx Laboratories' Current Deferred Revenue stood at $40.0 million in 2021, then dropped by 5.24% to $37.9 million in 2022, then dropped by 1.96% to $37.2 million in 2023, then dropped by 9.13% to $33.8 million in 2024, then increased by 4.33% to $35.3 million in 2025.
  • The last three reported values for Current Deferred Revenue were $35.3 million (Q4 2025), $35.7 million (Q3 2025), and $36.3 million (Q2 2025) per Business Quant data.